Liver pathology: Cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems

Modern Pathology

Volumn 13, Issue 6, 2000, Pages 679-704

  Ferrell, Linda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HEPATITIS; HEPATITIS VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TUMOR; MALE; PRIORITY JOURNAL;

EID: 0033945689     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880119     Document Type: Article

References (137)

1. Millward-Sadler GH. Cirrhosis. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, editors. Pathology of the liver. 3rd ed. London: Churchill Livingstone; 1994. p. 397-424.
2. Nevens F, Staessen D, Sciot R, Van Damme B, Desmet V, Fevery J, et al. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology 1994;106:459-63.
3. Baptista A, Bianchi L, De Groote J, Desmet V, Gedigk P, Korb G, et al. Alcoholic liver disease: morphological manifestations. Lancet 1981;1:707-11.
4. Lewis J, Mullick F, Ishak K, Ranard R, Ragsdale B, Perse R, et al. Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol 1990;21:59-67.
5. Babany G, Uzzan F, Larrey D, Degott C, Bourgeois P, Rene E, et al. Alcoholic-like liver lesions induced by nifedipine. J Hepatol 1989;9:252-5.
6. Snover D. The liver in systemic disease. In: Biopsy diagnosis of liver disease. 1st ed. Baltimore: Williams & Wilkins; 1992. p. 192-4.
7. Arcidi J, Moore G, Hutchins G. Hepatic morphology in cardiac dysfunction: a clinico-pathologic study of 1000 subjects at autopsy. Am J Pathol 1981;104:159-66.
8. Klatt E, Koss M, Young T, Macauley L, Martin S. Hepatic hyaline globules associated with passive congestion. Arch Pathol Lab Med 1988;112:510-3.
9. Kanel G, Ucci A, Kaplan M, Wolfe H. A distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol 1980;73:235-9.
10. Wanless I. Vascular disorders. In: MacSween R, Anthony P, Scheuer P, Burt A, Portmann B, editors. Pathology of the liver. 3rd ed. London: Churchill Livingstone; 1994. p. 535-62.
11. Shulman H, McDonald G. Liver disease after marrow transplantation. In: Sale G, Shulman H, editors. The pathology of bone marrow transplantation. New York: Masson Publishing; 1984. p. 104-35.
12. Lefkowitch J. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and cholangitis lenta. Hum Pathol 1982;13:19-24.
13. Nakanuma Y. Necroinflammatory changes in hepatic lobules in primary biliary cirrhosis with less well-defined cholestatic changes. Hum Pathol 1993;24:378-83.
14. Harrison R, Hubscher S. The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis. Histopathology 1991;19:321-7.
15. Wee A, Ludwig J, Coffey R, LaRusso N, Wiesner R. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985; 16:719-26.
16. Ludwig J, MacCarty R, LaRusso N, Krom R, Wiesner R. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis. Hepatology 1986;6:560-8.
17. Ben-Ari Z, Dhillon A, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993;18:10-5.
18. Goodman Z, McNally P, Davis D, Ishak K. Autoimmune cholangitis - a variant of primary biliary cirrhosis. Hepatology 1993;18:109A.
19. Taylor S, Dean P, Riely C. Primary autoimmune cholangitis: an alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 1994;18:91-9.
20. Colombato L, Alvarez F, Cote J, Huet P. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 1994;107:1839-43.
21. Dourakis S, Alexopoulou A, Hadziyannis S. Fulminant hepatitis after flutamide treatment. J Hepatol 1994;20:350-3.
22. Scheuer P. Viral hepatitis. In: MacSween R, Anthony P, Scheuer P, Burt A, Portmann B, editors. Pathology of the liver. 3rd ed. London: Churchill Livingstone; 1994. p. 243-67.
23. Ishak K, Sharp H. Developmental abnormalities and liver diseases in childhood. In: MacSween R, Anthony P, Scheuer P, Burt A, Portmann B, editors. Pathology of the liver. 3rd ed. London: Churchill Livingstone; 1994. p. 83-122.
24. Hadchouel M, Gautier M. Histopathologic study of the liver in the early cholestatic phase of alpha-1-antitrypsin deficiency. J Pediatr 1976;89:211-5.
25. Leblanc A, Odievre M, Hadchouel M, Gendrel D, Chaussain J, Rappaport R. Neonatal cholestasis and hypoglycemia: possible role of cortisol deficiency. J Pediatr 1981;99:577-80.
26. Phillips M, Blendis L, Poucell S, Offterson J, Petric M, Roberts E, et al. Syncytial giant cell hepatitis: sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 1991;324: 455-60.
27. Pappo O, Yunis E, Jordan J, Jaffe R, Mateo R, Fung J, et al. Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation. Am J Surg Pathol 1994;18:804-13.
28. Devaney K, Goodman Z, Ishak K. Postinfantile giant-cell transformation in hepatitis. Hepatology 1992;16:327-33.
29. Gastroenterology IWPotWCo. Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an International Working Party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994. Am J Gastroenterol 1994;89:S177-81.
30. Popper H, Shaffner F. The vocabulary of chronic hepatitis. N Engl J Med 1971;284:1154-6.
31. Acute and chronic hepatitis revisited. Review by an international group. Lancet 1977;2:914-9.
32. Cooksley W, Bradbear R, Robinson W, Harrison M, Halliday JW, Powell LW, et al. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 1986;6:345-8.
33. Popper H. Changing concepts of the evolution of chronic hepatitis and the role of piecemeal necrosis. Hepatology 1983;3:759-62.
34. Knodell R, Ishak K, Black W, Chen T, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
35. Ishak K, Baptista A, Bianchi L, Callea F, DeGroote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
36. Batts KP, Ludwig J. Chronic hepatitis - an update on terminology and reporting. Am J Surg Pathol 1995;19(12):1409-17.
37. Tsui W. New classification of chronic hepatitis and more. Adv Anat Pathol 1996;3:64-70.
38. Bedossa P, Bioulac-Sage P, Callard P, Chevallier M, Degott C, Deugnier Y, et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
39. Scheuer P, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko G. The pathology of hepatitis C. Hepatology 1992;15:567-71.
40. Gerber M, Krawczynski K, Alter M, Sampliner R, Margolis H. Histopathology of community acquired chronic hepatitis C. Mod Pathol 1992;5:483-6.
41. Ulich T, Anders K, Layfield L, Cheng L, Lewin K. Chronic active hepatitis of hepatitis B and non-A, non-B etiology. Arch Pathol Lab Med 1985;109:403-7.
42. Teixeira M, Weller I, Murray A, Bamber M, Thomas H, Sherlock S, et al. The pathology of hepatitis A in man. Liver 1982;2:52-60.
43. Kryger P, Christoffersen P. Liver histopathology of the hepatitis A virus infection: a comparison with hepatitis type B and non-A, non-B. J Clin Pathol 1983;36:650-4.
44. Gerber M, Thung S. The diagnostic value of immunohistochemical demonstration of hepatitis viral antigens in the liver. Hum Pathol 1987;18:771-4.
45. Govindarajan S, Valinluck B. Serum hepatitis B virus-DNA in chronic hepatitis B and delta infection. Arch Pathol Lab Med 1985;109:398-9.
46. Govindarajan S, DeCock K, Peters R. Morphologic and immunohistochemical features of fulminant delta hepatitis. Hum Pathol 1985;16:262-7.
47. Govindarajan S, DeCock K, Redeker A. Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies. Hepatology 1986;6:640-4.
48. Johnson P, McFarlane I, Feddleston A. The natural course and heterogeneity of autoimmune-type chronic active hepatitis. Semin Liver Dis 1991;11:187-96.
49. Johnson P, McFarlane I. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
50. Manns M. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance. Semin Liver Dis 1991;11:205-14.
51. Bach N, Thung S, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992;15:572-7.
52. Ferrell L, Steinkirchner T, Sterneck M, Lake J, Roberts J, Ascher N. Alpha-1-antitrypsin (AAT) globules in cirrhotic livers. Mod Pathol 1993;6:110A.
53. Pariente E, Degott C, Martin J, Feldmann G, Potet F, Benhamou J. Hepatocytic PAS-positive diastase-resistant inclusions in the absence of alpha-1-antitrypsin deficiency: high prevalence in alcoholic cirrhosis. Am J Clin Pathol 1981;76: 299-302.
54. Sterneck M, Ferrell L, Wright T, Read A, Roberts J, Ascher N, et al. Viral co-factors in patients with alcoholic cirrhosis undergoing liver transplantation. Gastroenterology 1991; 100(Suppl):A800.
55. Takase S, Takada N, Enomoto N, Yasuhara M, Takada A. Different types of chronic hepatitis in alcoholic patients: does chronic hepatitis induced by alcohol exist? Hepatology 1991;13:876-81.
56. Brillanti S, Masci C, Siringo S, DiFebo G, Miglioli M, Barbara L. Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 1991;13:347-50.
57. Davis G, Hoofnagle J, Waggoner J. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984;86:230-5.
58. Liaw Y, Chen J, Chen T. Acute exacerbation in patients with liver cirrhosis: a clinicopathological study. Liver 1990;10: 177-84.
59. Fattovich G, Brollo L, Alberti A, Realdi G, Pontisso P, Giustina G, et al. Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis. Liver 1990;10:141-6.
60. Linnen J, Wages J, Zhang-Keck Z, Fry K, Kwawczynski K, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
61. Mphahlele M, Lau G, Carman W. HGV: the identification, biology and prevalence of an orphan virus. Liver 1998;18: 143-55.
62. Cheung RC, Keeffe EB, Greenberg HB. Hepatitis G virus: is it a hepatitis virus? [see comments]. West J Med 1997; 167(1):23-33.
63. Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, et al. Influence of hepatitis G virus infection on the severity of liver disease. Ann Intern Med 1997;126(11):874-81.
64. Fried MW, Khudyakov YE, Smallwood GA, Cong M, Nichols B, Diaz E, et al. Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease. Hepatology 1997;25(5):1271-5.
65. Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing. Hepatology 1997;25(5):1266-70.
66. Haydon GH, Jarvis LM, Simpson KJ, Hayes PC, Simmonds P. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis. J Viral Hepatol 1997;4(1):45-9.
67. Sarrazin C, Herrmann G, Roth WK, Lee JH, Marx S, Zeuzem S. Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology. J Hepatol 1997;27(2): 276-83.
68. Matsumoto A, Yeo A, Shih W, Tanaka E, Kiyosawa K, Alter H. Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology 1999;30:283-8.
69. Kanda T, Yokosuka O, Ikeuchi T, Seta T, Kawai S, Imazeki F, et al. The role of TT virus infection in acute viral hepatitis. Hepatology 1999;29:1905-8.
70. Melato M, Laurino L, Mucli E, Valente M, Okuda K. Relationship between cirrhosis, liver cancer, and hepatic metastases: an autopsy study. Cancer 1989;64:455-9.
71. Crawford J. Pathologic assessment of liver cell dysplasia and benign liver tumors: differentiation from malignant tumors. Semin Diagn Pathol 1990;7:115-28.
72. Wanless I, Callea F, Craig J, Crawford J, Desmet VJ, Farber E, et al. Terminology of nodular lesions of the liver. Hepatology 1995;25:983-93.
73. Terada T, Hoso M, Nakanuma Y. Mallory body clustering in adenomatous hyperplasia in human cirrhotic livers: report of four cases. Hum Pathol 1989;20:886-90.
74. Nakanuma Y, Terada T, Ueda K, Terasaki S, Nonomura A, Matsui O. Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 1993;13:1-9.
75. Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H. Macroregenerative nodule of the liver: a clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 1988;61:99-105.
76. Ferrell L, Wright T, Lake J, Roberts J, Ascher N. Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology 1992;16:1372-81.
77. Terada T, Kadoya M, Nakanuma Y, Matsui O. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Cancer 1990;65:1994-2000.
78. Terada T, Nakanuma Y, Hoso M, Saito K, Sasaki M, Nonomura A. Fatty macroregenerative nodule in non-steatotic liver cirrhosis: a morphologic study. Virchows Arch A Pathol Anat Histopathol 1989;415:131-6.
79. Theise N, Fiel I, Hytiroglou P, Ferrell L, Schwartz M, Miller C, et al. Macroregenerative nodules in cirrhosis are not associated with elevated serum or stainable tissue alphafetoprotein. Liver 1995;15:30-4.
80. Nakanuma Y, Terada T, Terasaki S, Ueda K, Nonomura A, Kawahara E, et al. Atypical adenomatous hyperplasia in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion. Histopathology 1990;17:27-35.
81. Park Y, Yang C-T, Fernandez G, Cubukcku O, Thung S, Theise N. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol 1998; 22:656-62.
82. Ferrell L, Crawford J, Dhillon A, Scheuer P, Nakanuma Y. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 1993;17:1113-23.
83. Nakanuma Y, Ohta G. Small hepatocellular carcinoma containing many Mallory bodies. Liver 1984;4:128-33.
84. Nakanuma Y, Ohta G. Is Mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis. Cancer 1985; 55:2400-4.
85. Nakanuma Y, Ohta G. Expression of Mallory bodies in hepatocellular carcinoma in man and its significance. Cancer 1986;57:81-6.
86. Kondo Y, Nakajima T. Pseudoglandular hepatocellular carcinoma: a morphogenetic study. Cancer 1987;60:1032-7.
87. Bottles K, Cohen M, Holly E, Chui S, Abele J, Cello J, et al. A step-wise logistic regression analysis of hepatocellular carcinoma. Cancer 1988;62:558-63.
88. Cohen M, Haber M, Holly E, Ahn D, Bottles K, Stoloff A. Cytologic criteria to distinguish hepatocellular carcinoma from nonneoplastic liver. Am J Clin Pathol 1991;95:125-30.
89. Cochand-Priollet B, Chagnon S, Ferrand J, Blery M, Hoang C, Galian A. Comparison of cytologic examination of smears and histologic examination of tissue cores obtained by fine needle aspiration biopsy of the liver. Acta Cytol 1987;31:476-80.
90. Sangalli G, Livraghi T, Giordano F. Fine needle biopsy of hepatocellular carcinoma: improvement in diagnosis by microhistology. Gastroenterology 1989;96:524-6.
91. Kung I, Chan S, Fung K. Fine-needle aspiration in hepatocellular carcinoma: combined cytologic and histologic approach. Cancer 1991;67:673-80.
92. Ljung B, Ferrell L. Fine needle aspiration biopsy of the liver: diagnostic problems. In: Ferrell L, editor. Diagnostic problems in liver pathology. Philadelphia: Hanley & Belfus; 1994. p. 161-84. (Pathology: State of the Art Reviews; vol 3).
93. Ljung B, Ferrell L. Fine needle aspiration biopsy of the liver: diagnostic problems. In: Ferrell L, editor. Diagnostic problems in liver pathology. Philadelphia: Hanley & Belfus; 1994. p. 161-84. (Pathology: State of the Art Reviews; vol 3).
94. Fucich L, Cheles M, Thung S, Gerber M, Marrogi A. Primary versus metastatic hepatic carcinoma: an immunohistochemical study of 34 cases. Arch Pathol Lab Med 1994;118: 927-30.
95. Johnson D, Herndier B, Medieros L, Warnke R, Rouse R. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 1988;12:187-97.
96. Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M. The expression of cytokeratins 7, 19, 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996;9:901-9.
97. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 1995; 26(9):956-64.
98. Wang N, Zee S, Zarbo R, Bacchi C, Gown A. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-107.
99. Carrozza M, Calafati S, Edmonds P. Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas. Acta Cytol 1991;35:221-4.
100. Hurlimann J, Gardiol D. Immunohistochemistry in the differential diagnosis of liver carcinomas. Am J Surg Pathol 1991;15:280-8.
101. Garcia de Davila M, Gonzalez-Crussi F, Mangkornkanok M. Fibrolamellar carcinoma of the liver in a child: ultrastructural and immunohistologic aspects. Pediatr Pathol 1987;7: 319-31.
102. Ruck P, Harms D, Kaiserling E. Neuroendocrine differentiation in hepatoblastoma: an immunohistochemical investigation. Am J Surg Pathol 1990;14:847-55.
103. Krishna M, Lloyd R, Batts K. Detection of albumin messenger RNA in hepatic and extrahepatic neoplasms - a marker of hepatocellular differentiation. Am J Surg Pathol 1997;21: 147-52.
104. Wanless I, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5: 1194-200.
105. Mathieu D, Zafrani E, Anglade M, Dhumeaux D. Association of focal nodular hyperplasia and hepatic hemangioma. Gastroenterology 1989;97:154-7.
106. Ndimbie O, Goodman Z, Chase R, Ma C, Lee M. Hemangiomas with localized nodular proliferation of the liver: a suggestion on the pathogenesis of focal nodular hyperplasia. Am J Surg Pathol 1990;14:142-50.
107. Stromeyer F, Ishak K. Nodular transformation (nodular regenerative hyperplasia) of the liver: a clinicopathologic study of 30 cases. Hum Pathol 1981;12:660-71.
108. Nakanuma Y, Ohta G. Nodular hyperplasia of the liver in primary biliary cirrhosis of early histological stages. Am J Gastroenterol 1987;82:8-10.
109. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990;12:460-5.
110. Wanless I. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97.
111. Yutani C, Imakita M, H I-u, Okubo S, Naito M, Kunieda T. Nodular regenerative hyperplasia of the liver associated with primary pulmonary hypertension. Hum Pathol 1988; 19:726-31.
112. Nakanuma Y, Ohta G, Sasaki K. Nodular regenerative hyperplasia of the liver associated with polyarteritis nodosa. Arch Pathol Lab Med 1984;108:133-5.
113. Chandra R, Kapur S, Kelleher J, Luban N, Patterson K. Benign hepatocellular tumors in the young: a clinicopathologic spectrum. Arch Pathol Lab Med 1984;108:168-71.
114. Tao L. Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma: cytomorphology and mechanism of malignant transformation. Cancer 1991;68:341-7.
115. Ferrell L. Hepatocellular carcinoma arising in a focus of multilobular adenoma. Am J Surg Pathol 1993;17:525-9.
116. Poe R, Snover D. Adenomas in glycogen storage disease type 1: two cases with unusual histologic features. Am J Surg Pathol 1988;12:477-83.
117. Craig J, Peters R, Edmondson H, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980;46:372-9.
118. Berman M, Sheahan D. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988;19:784-94.
119. Omata M, Peters R, Tatters D. Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver 1981;1:33-49.
120. Weinberg A, Finegold M. Primary hepatic tumors of childhood. Hum Pathol 1983;14:512-37.
121. Stocker J. Hepatoblastoma. Semin Diagn Pathol 1994;11: 136-43.
122. Conran R, Hitchcock C, Waclawiw M, Stocker J, Ishak K. Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol 1992;12:167-83.
123. Haas J, Muczynski K, Krailo M, Ablin A, Land V, Vietti T, et al. Histopathology, and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989;64:1082-95.
124. Fasano M, Theise N, Nalesnik M, Goswami S, Garcia de Davila MT, Finegold MJ, et al. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Mod Pathol 1998;11:934-8.
125. Abenoza P, Manivel C, Wick M, Hagen K, Dehner L. Hepatoblastoma: an immunohistochemical and ultrastructural study. Hum Pathol 1987;18:1025-35.
126. Saxena R, Leake J, Shafford E, Davenport M, Mowat A, Pritchard J, et al. Chemotherapy effects on hepatoblastoma: a histological study. Am J Surg Pathol 1993;17:1266-71.
127. Stocker J, Ishak K. Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Pediatr Pathol 1983;1:245-67.
128. Ishak K, Sesterhenn I, Goodman Z, Rabin L, Stromeyer F. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol 1984;15:839-52.
129. Gray M, Rosenberg A, Dickersin G, Bhan A. Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol 1990;21:212-7.
130. Selby D, Stocker J, Ishak K. Angiosarcoma of the liver in childhood: a clinicopathologic and follow-up study of 10 cases. Pediatr Pathol 1992;12:485-98.
131. Stocker J, Ishak K. Undifferentiated (embryonal) sarcoma of the liver: report of 31 cases. Cancer 1978;42:336-48.
132. Aoyama C, Hachitanda Y, Sato J, Said J, Shimada H. Undifferentiated (embryonal) sarcoma of the liver: a tumor of uncertain histogenesis showing divergent differentiation. Am J Surg Pathol 1991;15:615-24.
133. Lack E, Schloo B, Azumi N, Travis W, Grier H, Kozakewich H. Undifferentiated (embryonal) sarcoma of the liver: clinical and pathologic study of 16 cases with emphasis on immunohistochemical features. Am J Surg Pathol 1991;15:1-16.
134. Tsui W, Colombari R, Bonetti F, Portmann BC, Thung SN, Ferrell LD, et al. Hepatic angiomyolipoma: delineation of unusual morphological variants. Am J Surg Pathol 1999;23: 34-48.
135. Tsui W, Yuen A, Ma K, Tse C. Hepatic angiomyolipomas with a deceptive trabecular pattern and HMB-45 reactivity. Histopathology 1992;21:569-73.
136. Linton P, Ahn W, Schwartz M, Ciller C, Thung S. Angiomyolipoma of the liver: immunohistochemical study of a case. Liver 1991;11:158-61.
137. Chan J, Tsang W, Pau M, Tang M, Pang S, Fletcher C. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. Histopathology 1993;22:445-55.